These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35050996)

  • 1. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT
    Parrera GS; Astacio H; Tunga P; Anderson DM; Hall CL; Richardson JS
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.
    Richardson JS; Parrera GS; Astacio H; Sahota H; Anderson DM; Hall C; Babinchak T
    Clin Infect Dis; 2020 Apr; 70(9):1950-1957. PubMed ID: 31209461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
    Anderson DM; Kumar VR; Arper DL; Kruger E; Bilir SP; Richardson JS
    PLoS One; 2019; 14(11):e0224700. PubMed ID: 31697731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
    Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs.
    Barker D; Gillum KT; Niemuth NA; Kodihalli S
    PLoS One; 2019; 14(9):e0222670. PubMed ID: 31527885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.
    Schussler E; Sobel J; Hsu J; Yu P; Meaney-Delman D; Grammer LC; Nowak-Wegrzyn A
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S65-S72. PubMed ID: 29293931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product.
    Beliveau M; Anderson D; Barker D; Kodihalli S; Simard E; Hall C; Richardson JS
    Clin Pharmacol Ther; 2022 Jul; 112(1):171-180. PubMed ID: 35467014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foodborne botulism treated with heptavalent botulism antitoxin.
    Hill SE; Iqbal R; Cadiz CL; Le J
    Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model.
    Emanuel A; Qiu H; Barker D; Takla T; Gillum K; Neimuth N; Kodihalli S
    PLoS One; 2019; 14(1):e0209019. PubMed ID: 30633746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(10):299. PubMed ID: 20300057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
    Hatheway CH; Snyder JD; Seals JE; Edell TA; Lewis GE
    J Infect Dis; 1984 Sep; 150(3):407-12. PubMed ID: 6481185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review.
    Griese SE; Kisselburgh HM; Bartenfeld MT; Thomas E; Rao AK; Sobel J; Dziuban EJ
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S17-S29. PubMed ID: 29293924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.
    Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W
    Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of foodborne botulism in Alexandria, Egypt: modulating indications for administration of heptavalent botulinum antitoxin.
    Ghitani SA; Ghanem MA; Sultan EA; Atef M; Henaidy MF
    Environ Sci Pollut Res Int; 2021 Nov; 28(43):61547-61553. PubMed ID: 34184216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitoxin accident during botulism].
    Chaussinand JP; Loyer JJ; Paulin P
    Ann Fr Anesth Reanim; 1992; 11(2):241-2. PubMed ID: 1503305
    [No Abstract]   [Full Text] [Related]  

  • 17. Type E botulism.
    Horowitz BZ
    Clin Toxicol (Phila); 2010 Nov; 48(9):880-95. PubMed ID: 21171846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
    Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
    Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine botulinum antitoxin for the treatment of infant botulism.
    Vanella de Cuetos EE; Fernandez RA; Bianco MI; Sartori OJ; Piovano ML; Lúquez C; de Jong LI
    Clin Vaccine Immunol; 2011 Nov; 18(11):1845-9. PubMed ID: 21918119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt.
    Hibbs RG; Weber JT; Corwin A; Allos BM; Abd el Rehim MS; Sharkawy SE; Sarn JE; McKee KT
    Clin Infect Dis; 1996 Aug; 23(2):337-40. PubMed ID: 8842274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.